HBIO

Harvard Bioscience, Inc.

2.82 USD
-0.07 (-2.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Harvard Bioscience, Inc. stock is down -16.32% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 23 June’s closed higher than May.

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as instruments and accessories for tissue and organ-based lab research.